<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00398801</url>
  </required_header>
  <id_info>
    <org_study_id>U01DK074008 GpR</org_study_id>
    <secondary_id>U01DK074008</secondary_id>
    <nct_id>NCT00398801</nct_id>
  </id_info>
  <brief_title>Gastroparesis Registry</brief_title>
  <acronym>GpR</acronym>
  <official_title>Gastroparesis Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Gastroparesis Registry (GpR) is an observational study to clarify the epidemiology,&#xD;
      natural history, clinical course, and other outcomes of gastroparesis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Gastroparesis Registry (GpR) is an observational study to clarify the epidemiology,&#xD;
      natural history, clinical course, and other outcomes of gastroparesis. The Gastroparesis&#xD;
      Registry will also provide a resource to inform the development of clinical trials and&#xD;
      ancillary studies of the epidemiology, etiology, pathophysiology, and impact of&#xD;
      gastroparesis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 2006</start_date>
  <completion_date type="Actual">March 2011</completion_date>
  <primary_completion_date type="Actual">March 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">591</enrollment>
  <condition>Gastroparesis</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma and serum&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Tertiary care centers for patients with symptoms of gastroparesis&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Symptoms of gastroparesis of at least 12 weeks duration (do not have to be contiguous)&#xD;
             with varying degrees of nausea, vomiting, abdominal pain, early satiety, post-prandial&#xD;
             fullness,&#xD;
&#xD;
          -  Completion of a 4-hour scintigraphic low fat Egg Beaters gastric emptying study&#xD;
&#xD;
          -  Patients with either or both abnormal 2 hour (&gt;60% retention) and 4 hour (&gt;10%&#xD;
             retention) gastric emptying will be enrolled and classified as definite gastroparesis&#xD;
             (Gp)&#xD;
&#xD;
          -  Patients with normal gastric emptying, but with symptoms of gastroparesis may be&#xD;
             enrolled and classified as possible gastroparesis or gastroparesis-like with normal&#xD;
             gastric emptying (GLNGE)&#xD;
&#xD;
          -  Age at least 18 years at initial screening visit&#xD;
&#xD;
          -  Ability and willingness to participate in follow-up&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to comply with or complete the gastric emptying scintigraphy&#xD;
&#xD;
          -  Presence of other conditions that could explain the patient's symptoms:&#xD;
&#xD;
          -  Pyloric or intestinal obstruction&#xD;
&#xD;
          -  Active inflammatory bowel disease&#xD;
&#xD;
          -  Eosinophilic gastroenteritis&#xD;
&#xD;
          -  Neurological conditions such as increased intracranial pressure, space occupying or&#xD;
             inflammatory/infectious lesions&#xD;
&#xD;
          -  Acute liver failure&#xD;
&#xD;
          -  Advanced liver disease (Child's B or C)&#xD;
&#xD;
          -  Acute renal failure&#xD;
&#xD;
          -  Untreated chronic renal failure (serum creatinine &gt;3 mg/dL)&#xD;
&#xD;
          -  Total or subtotal gastric resection (patients with prior fundoplication or&#xD;
             postvagotomy gastroparesis after pyloroplasty or antrectomy with Billroth I, Billroth&#xD;
             II, or Roux-en-Y gastrojejunostomy will be eligible for enrollment)&#xD;
&#xD;
          -  Any other plausible structural or metabolic cause&#xD;
&#xD;
          -  Any other condition, which in the opinion of the investigator would interfere with&#xD;
             study requirements&#xD;
&#xD;
          -  Inability to obtain informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James Tonascia, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University Bloomberg School of Public Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Henry P Parkman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Temple University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>William L Hasler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thomas L Abell, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Mississippi Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pankaj J Pasricha, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kenneth L Koch, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wake Forest University Health Sciences</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Richard W McCallum, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Texas Tech University Health Science Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>California Pacific Medical Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305-5187</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Michigan Medical Center</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Mississippi Medical Center</name>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <zip>39216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wake Forest University Health Sciences</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Temple University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19140</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Tech University Health Science Center (TTUHSC)</name>
      <address>
        <city>El Paso</city>
        <state>Texas</state>
        <zip>79905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www2.niddk.nih.gov/</url>
    <description>National Institute of Diabetes and Digestive and Kidney Diseases</description>
  </link>
  <link>
    <url>https://jhuccs1.us/gpcrc/</url>
    <description>Gastroparesis Clinical Research Consortium</description>
  </link>
  <results_reference>
    <citation>Parkman HP, Yates K, Hasler WL, Nguyen L, Pasricha PJ, Snape WJ, Farrugia G, Koch KL, Calles J, Abell TL, Sarosiek I, McCallum RW, Lee L, Unalp-Arida A, Tonascia J, Hamilton F. Cholecystectomy and clinical presentations of gastroparesis. Dig Dis Sci. 2013 Apr;58(4):1062-73. doi: 10.1007/s10620-013-2596-y. Epub 2013 Mar 2.</citation>
    <PMID>23456496</PMID>
  </results_reference>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>November 13, 2006</study_first_submitted>
  <study_first_submitted_qc>November 13, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 14, 2006</study_first_posted>
  <last_update_submitted>August 31, 2021</last_update_submitted>
  <last_update_submitted_qc>August 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>gastroparesis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroparesis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data are available at the NIDDK Central Repository: https://repository.niddk.nih.gov/studies/gpr/?query=gpr</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>Data deposited 05Jul2016</ipd_time_frame>
    <ipd_access_criteria>Registered user of NIDDK Central Repository</ipd_access_criteria>
    <ipd_url>https://repository.niddk.nih.gov/home/</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

